Factor VII assay performance: An analysis of the North American Specialized Coagulation Laboratory Association proficiency testing results

International Journal of Laboratory Hematology

Volumn 35, Issue 3, 2013, Pages 314-321

  Zantek, N D ^a   Hsu, P ^b   Refaai, M A ^c   Ledford Kraemer, M ^d   Meijer, P ^e   Van Cott, E M ^f  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d CLOT ED   (United States)

^e ECAT Foundation   (Netherlands)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

External quality control of diagnostic assays and tests; Factor VII; North American specialized coagulation laboratory association; Thromboplastin

Indexed keywords

BLOOD CLOTTING FACTOR 7; THROMBOPLASTIN;

ABNORMAL LABORATORY RESULT; ARTICLE; LABORATORY TEST; NORTH AMERICA; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ANIMALS; BLOOD COAGULATION TESTS; CALIBRATION; CANADA; FACTOR VII; FACTOR VII DEFICIENCY; HUMANS; LABORATORIES; LABORATORY PROFICIENCY TESTING; RABBITS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOPLASTIN; UNITED STATES;

EID: 84876466971     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12083     Document Type: Article

References (7)

1. Cooper DN, Millar DS, Wacey A, Pemberton S, Tuddenham EG. Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost 1997;78:151-60.
2. Peyvandi F, Di Michele D, Bolton-Maggs HB, Lee CA, Tripodi A, Srivastava A. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 2012;10:1938-43.
3. Mariani G, Hermann FH, Dolce A, Batorova A, Etros D, Peyvandi F, Wulff K, Schved JF, Auerswald G, Ingerslev J, Bernardi F, for the International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VIII deficiency. Thromb Haemost 2005;93:481-7.
4. Hermann FH, Wulff K, Auerswold G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollman H, Ruiz-Saez A, De Bosch N, Salazar-Sanchex L, for the Greifswald Factor FVII Deficiency Study Group. Factor VII deficiency: clinical manifestations of 717 subject from Europe and Latin American with mutations in the factor 7 gene. Haemophilia 2009;15:267-80.
5. Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, Pergantou H, Platokouki H, Giangrande P, Peerlinck K, Celkan T, Ozdemir N, Bidlingmaier C, Ingerslev J, Giansily-Blaizot M, Schved JF, Gilmore R, Gadisseur A, Benedik-Dolnicar M, Kitanovski L, Mikovic D, Mussalam KM, Rosendaal FR, European Network of Rare Bleeding Disorders Group. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding disorders. J Thromb Haemost 2012;10:615-21.
6. Benlakhl F, Mura T, Schved JK, Giansily-Blaizot M, on behalf of the French Study Group of FVII Deficiency. A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor VII-deficient patients. J Thromb Haemost 2011;9:1149-56.
7. Acharya SS, Coughlin A, Dimichele DM, North American Rare Bleeding Disorder Study Group. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004;2:248-56.